Anika Therapeutics reported $91.39M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acorda Therapeutics ACOR:US $ 23.13M 8.75M
Agenus AGEN:US $ 228.38M 19.32M
Agios Pharmaceuticals AGIO:US $ 88.54M 8.52M
Anika Therapeutics ANIK:US $ 91.39M 1.07M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Chemocentryx CCXI:US $ 44.4M 3.82M
Clovis Oncology CLVS:US $ 94.58M 27.66M
Enanta Pharmaceuticals ENTA:US $ 28.37M 12.62M
Halozyme Therapeutics HALO:US $ 90.93M 26.9M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Immunogen IMGN:US $ 373.87M 63.79M
Insmed INSM:US $ 416.08M 99.63M
Integra Lifesciences IART:US $ 447.15M 40.06M
Intrexon XON:US $ 43.84M 3.52M
Karyopharm Therapeutics KPTI:US $ 82.25M 71.01M
Ligand Pharmaceuticals LGND:US $ 153.22M 138.22M
Macrogenics MGNX:US $ 21.47M 25.86M
Merit Medical Systems MMSI:US $ 63M 9.13M
Peregrine Pharmaceuticals PPHM:US $ 115.14M 11.03M
Rigel Pharmaceuticals RIGL:US $ 27.2M 2.52M
Sangamo Biosciences SGMO:US $ 117.7M 2.55M
Stryker SYK:US $ 1044M 414M
Surmodics SRDX:US $ 20.07M 4.64M
Veracyte VCYT:US $ 153.45M 10.17M
Xencor XNCR:US $ 49.41M 28.86M
Zimmer Biomet Holdings Inc ZBH:US $ 386.4M 49.4M